Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Rectal Diseases 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasms 1Kidney Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gallbladder Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

Irinotecan 4Oxaliplatin 3Bevacizumab 3trimebutine 3-thiocarbamoylbenzenesulfonate 2pembrolizumab 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Capecitabine 2Aspirin 2Ascorbic Acid 2repotrectinib 1pralsetinib 1napabucasin 1ibrutinib 1guadecitabine 1encorafenib 1alectinib 1XELOX 1Sutures 1Surgical Instruments 1Polyethylene Glycols 1Optical Imaging 1Ocoxin 1Levoleucovorin 1KRN-330 1Diagnosis 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Diseases × guadecitabine × Gastrointestinal × Clear all
NCT01966289 2021-03-30

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
18 enrolled
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡